טוען...
Honokiol mediated inhibition of PI3K/mTOR pathway: A potential strategy to overcome immunoresistance in glioma, breast and prostate carcinoma without impacting T cell function
Inhibition of the PI3K/mTOR pathway is an appealing method for decreasing immunoresistance and augmenting T cell mediated immunotherapy. A major impediment to this strategy is the impact of conventional PI3K/mTOR pathway inhibitors on T cell function. In particular, Rapamycin, a well known immunosup...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3795513/ https://ncbi.nlm.nih.gov/pubmed/19483651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e3181a8efe6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|